Differences in Vascular Response Between Primary and Transplanted Tumours
Author Information
Author(s): S.B. Field, S. Needham, I.A. Burney, R.J. Maxwell, J.E. Coggle, J.R. Griffiths
Primary Institution: MRC Cyclotron Unit, Hammersmith Hospital
Hypothesis
Is the vascular response similar in primary tumours and in transplanted tumours derived from them?
Conclusion
The study found that transplanted tumours responded significantly better to hydralazine than primary tumours.
Supporting Evidence
- 16 out of 17 transplanted tumours responded to hydralazine.
- Only 4 out of 11 primary tumours responded to hydralazine.
- The difference in response rates between primary and transplanted tumours was statistically significant.
Takeaway
This study looked at how two types of tumours react to a drug that affects blood flow, and found that one type reacted much more than the other.
Methodology
The study involved injecting hydralazine into mice with primary and transplanted tumours and measuring changes in metabolism using 31P Magnetic Resonance Spectroscopy.
Potential Biases
The results may be influenced by the differences in the histology and growth rates of the tumours.
Limitations
The study had a small sample size and the primary tumours were all radiation-induced, which may affect their response.
Participant Demographics
Mice used were of various strains including SAS/4, CD1, CBA, and C57BI.
Statistical Information
P-Value
0.001
Statistical Significance
p=0.001
Want to read the original?
Access the complete publication on the publisher's website